Docetaxel (Taxotere®) in der First-line-Therapie des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms (NSCLC)

Publisher： Karger

E-ISSN： 2296-5262|26|7|26-32

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.7, 2004-11, pp. : 26-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabin in der First-line-Therapie des lokal fortgeschrittenen und metastasierten nicht-kleinzelligen Bronchialkarzinoms (NSCLC): Ergebnisübersicht randomisierter Phase-III-Studien

By  

Oncology Research and Treatment, Vol. 28, Iss. 1, 2005-03 ,pp. : 1-28

Karger

Access to resources Recommend Favorite

Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) im lokal fortgeschrittenen Stadium (inoperables IIIA/IIIB)

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 11-14

Karger

Access to resources Recommend Favorite

Docetaxel als therapeutische Option für die adjuvante Chemotherapie des nicht-kleinzelligen Bronchialkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 22-24

Karger

Access to resources Recommend Favorite

Kombination mit Irinotecan – die Referenztherapie in der First-line-Therapie des fortgeschrittenen Kolorektalkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 32-34

Karger

Access to resources Recommend Favorite

Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) im Stadium IV

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 15-19

Karger

Access to resources Recommend Favorite